Legal heavyweight Greenberg Traurig has welcomed Peter A. Arhangelsky into their ranks as a shareholder in the healthcare and FDA practice, based out of their Phoenix office. According to the announcement from the firm on Thursday, the move marks further growth in their FDA practice.
Arhangelsky’s career has seen him handle enforcement actions and private litigation on behalf of companies producing food, beverages, dietary supplements, and over-the-counter drugs. Greenberg Traurig noted his particular experience in managing claims related to food and dietary supplement advertising. This has seen him tackle cases under the California False Advertising Law, the Unfair Competition Law, the California Consumer Legal Remedies Act, and the Lanham Act.
Before joining Greenberg Traurig, Arhangelsky was affiliated with Emord & Associates, P.C. His experience in navigating the complex landscape of the FDA has proven invaluable to companies in what can often be a sheer and complex regulatory environment.
The full details of Arhangelsky’s move can be found in the reporting by Bloomberg Law.